Table of Content - Anti Venom Market

Global anti venom market growth is driven by rising incidence of snake bites and scorpion stings across tropical and sub-tropical regions of the world. Each year over 5 million people are bitten by snakes, out of which, around 2.7 million cases result in envenoming and around 100,000 deaths. There has been rising demand for anti-venom as the availability of effective anti-venoms has improved survival and recovery rates for victims of snake bites in many countries. Leading manufacturers are engaging in development of novel anti-venoms through reforms in production techniques using modern immunological and biochemical methods. Rising investments towards building awareness about timely treatment and availability of anti-venoms can also drive the market growth.

Market Dynamics:

Global anti venom market growth is primarily driven by increasing incidence of snake bites and scorpion stings globally. According to the World Health Organization, around 5.4 million people suffer from snake bites each year and about 2.7 million are envenomed with around 137,000 deaths. Rising investments by market players and governments towards educating rural populations, improving access to healthcare facilities and ensuring availability of anti-venoms across remote areas can offer lucrative opportunities. However, high costs of anti-venoms, short shelf-life requiring constrained and controlled storage and transportation can limit its widespread adoption. Lack of awareness, traditional beliefs and geographical barriers restrict timely treatment seeking for victims in developing nations. Market players involved in research and production of innovative, more effective and affordable anti-venoms can offer market growth opportunities.

Key features of the study:

This report provides in-depth analysis of the global anti venom market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global anti venom market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Bharat Serums & Vaccines, Haffkine Bio-Pharmaceutical Corporation, Vins Bioproducts, Bharat Biotech, and Serum Institute of India
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global anti venom market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global anti venom market

Detailed Segmentation-

By Anti-venom Type
- Polyvalent
- Monovalent
By Product Type
- Snake Antivenom
- Scorpion Anti-venom
- Spider Anti-venom
- Others
By End User
- Hospitals & clinics
- Ambulatory Surgical Centers
- Research Institutes
- Others
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Pfizer, Inc.
- Merck & Co., Inc.
- Sanofi Pasteur
- 4CSL Limited
- Haffkine Bio-Pharmaceutical Corporation Ltd.
- Instituto Bioclon S.A. de C.V.
- Rare Disease Therapeutics, Inc.
- Vins Bioproducts Limited
- Bharat Serums and Vaccines Limited
- Serum Institute of India Pvt. Ltd.
- Incepta Pharmaceuticals Ltd.
- MicroPharm Limited
- Laboratorios Silanes S.A.
- BTG plc
- Vacsera
- Indian Immunologicals Limited
- AfrIPI (African Institute of Biomedical Science and Technology)

Table of Contents

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snapshot, By Anti-venom Type
  - Market Snapshot, By Product Type
  - Market Snapshot, By End User
  - Market Snapshot, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter’s Analysis
Global Anti Venom Market - Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the Market
Global Anti Venom Market, By Anti-venom Type, 2019 – 2031, (USD Mn)
- Overview
  - Market Share Analysis, 2024 and 2031 (%)
  - Y-o-Y Growth Analysis, 2019 – 2031
  - Segment Trends
- Polyvalent
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
- Monovalent
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
Global Anti Venom Market, By Product Type, 2019 – 2031, (USD Mn)
- Overview
  - Market Share Analysis, 2024 and 2031 (%)
  - Y-o-Y Growth Analysis, 2019 – 2031
  - Segment Trends
- Snake Antivenom
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
- Scorpion Anti-venom
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
- Spider Anti-venom
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
- Others
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
Global Anti Venom Market, By End User, 2019 – 2031, (USD Mn)
- Overview
  - Market Share Analysis, 2024 and 2031 (%)
  - Y-o-Y Growth Analysis, 2019 – 2031
  - Segment Trends
- Hospitals & Clinics
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
- Ambulatory Surgical Centers
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
- Research Institutes
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
- Others
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
Global Anti Venom Market, By Region, 2019 – 2031, (USD Mn)
- Introduction
  - Market Share Analysis, By Region, 2024 and 2031 (%)
  - Y-o-Y Growth Analysis, For Region, 2019–2031
  - Regional Trends
- North America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Anti-venom Type, 2019 - 2031, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Mn)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Anti-venom Type, 2019 - 2031, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Mn)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Anti-venom Type, 2019 - 2031, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Mn)
    - U.K.
    - Germany
    - Italy
    - France
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Anti-venom Type, 2019 - 2031, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Mn)
    - China
    - India
    - Japan
    - ASEAN
    - Australia
    - South Korea
    - Rest of Asia Pacific
- Middle East
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Anti-venom Type, 2019 - 2031, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Mn)
    - GCC Countries
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Anti-venom Type, 2019 - 2031, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 – 2031, (USD Mn)
    - North Africa
    - Central Africa
    - South Africa
Competitive Landscape
- Company Profiles
  - Pfizer, Inc.
    - Company Highlights
    - Anti-venom Type Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Merck & Co., Inc.
    - Company Highlights
    - Anti-venom Type Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Sanofi Pasteur
    - Company Highlights
    - Anti-venom Type Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - 4CSL Limited
    - Company Highlights
    - Anti-venom Type Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Haffkine Bio-Pharmaceutical Corporation Ltd.
    - Company Highlights
    - Anti-venom Type Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Instituto Bioclon S.A. de C.V.
    - Company Highlights
    - Anti-venom Type Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Rare Disease Therapeutics, Inc.
    - Company Highlights
    - Anti-venom Type Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Vins Bioproducts Limited
    - Company Highlights
    - Anti-venom Type Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Bharat Serums and Vaccines Limited
    - Company Highlights
    - Anti-venom Type Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Serum Institute of India Pvt. Ltd.
    - Company Highlights
    - Anti-venom Type Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Incepta Pharmaceuticals Ltd.
    - Company Highlights
    - Anti-venom Type Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - MicroPharm Limited
    - Company Highlights
    - Anti-venom Type Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Laboratorios Silanes S.A.
    - Company Highlights
    - Anti-venom Type Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - BTG plc
    - Company Highlights
    - Anti-venom Type Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Vacsera
    - Company Highlights
    - Anti-venom Type Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Indian Immunologicals Limited
    - Company Highlights
    - Anti-venom Type Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - AfrIPI (African Institute of Biomedical Science and Technology)
    - Company Highlights
    - Anti-venom Type Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact

*Browse 32 market data tables and 28 figures on "Anti Venom Market” - Global forecast to 2031

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now

Credibility and Certifications

860519526

9001:2015

27001:2022

Need a Custom Report?

EXISTING CLIENTELE